Affiliation:
1. Yudino — Russian Scientific Centre for Medical Rehabilitation and Balneology
Abstract
The article describes relevant data on the etiology of rosacea and the clinical forms of the disease. A pathogenetic substantiation of the feasibility of using botulinum toxin type A (BTA) with an erythematous-telangiectatic subtype of rosacea is given. A study was conducted involving 30 patients with ETR to treat the manifestations of this dermatosis using BTA injections in mesotechnics. As a result, we established a positive role for the use of BTA in ETP based on the use of a visual analogue scale (VAS), and also obtained data on the distribution of trigger factors and associated pathologies. We came to conclusions about the effectiveness of the botulinum toxin method for rosacea and the feasibility of further studies to optimize the dose and frequency of administration of type A botulinum toxin for a more pronounced and lasting result.
Subject
Materials Chemistry,Economics and Econometrics,Media Technology,Forestry
Reference20 articles.
1. Chauhan N., Ellis D. A. Rosacea: pathophysiology and management principles // Facial Plast. Surg. Clin. North Am. 2013. Vol. 21. N 1. P. 127–136.
2. Steinhoff M., Schmelz M., Schauber J. Facial erythema of rosacea — aetiology, different pathophysiologies and Treatment Options. Acta Derm Venereol 2015 Dec 30.
3. Wilkin J., Dahl M., Detmar M., Drake L., Feinstein A., Odom R. (2002) Standard classifi cation of rosacea: report of the National Rosacea Society Expert Committee on the classifi cation and staging of rosacea. J Am Acad Dermatol., 46 (4): 584–7.
4. Tan J, et al. Br J Dermatol 2013; 169 (3): 555–62.
5. Yuraitis M., Jacob C. I. Botulinum toxin for the treatment of facial flushing. Dermatol Surg 2004; 30 (1): 102–104.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献